Senior Manager, Global Commercial Strategy - Multiple Myeloma jobs in United States
cer-icon
Apply on Employer Site
company-logo

Gilead Sciences · 1 month ago

Senior Manager, Global Commercial Strategy - Multiple Myeloma

Kite, a Gilead Sciences company, is focused on transforming cancer treatment through innovative therapies. The Senior Manager, Global Commercial Strategy for Multiple Myeloma will lead strategic initiatives and cross-functional team coordination to ensure successful global brand launch and execution.

BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Lead coordination, facilitation, process management for cross-functional global strategic deliverables (Global Strategic Plan, Plan of Action/Launch Priorities), global launch readiness (Launch Readiness Reviews)
Lead strategic planning, objectives, and support logistics for global Advisory Boards with key external audiences
Co-lead and oversee team operations, including global commercial decision-making forums (Global Brand Team with Kite and Arcellx cross-functional leads)
Support launch readiness, execution excellence, and best practice sharing in close partnership with Regional and Local teams
Support strategic planning for global congresses and OL engagement
Synthesize market landscape and competitive insights to inform commercial perspective for differentiated brand strategy and lifecycle management
Support optimal resource allocation, by tracking priorities, budget, contract submissions
Support ad hoc workstreams that arise within global commercial and program team
Anticipated international and domestic travel up to 20%

Qualification

Global strategic marketingGlobal product launchCross-functional collaborationMarket researchBrand positioningStrategic planningLearning agilityTeam empowermentCommunication skillsOrganizational skills

Required

PhD /PharmD and 2 years of experience
OR Master's degree and 6 years of experience
OR Bachelor's degree and 8 years of experience
OR Associate degree and 10 years of experience
OR High School Diploma / GED degree and 12 years of experience

Preferred

Pharmaceutical global strategic marketing experience, with strong grasp of marketing strategy, market research, segmentation, brand positioning, tactical plan development
Global product launch experience, preferably in hematology and/or cell therapy
Demonstrated ability to partner with regional and local teams to ensure alignment to global strategy while accounting for regional nuances for successful execution
Experience delivering results in co-commercialization partnerships
Strong collaboration skills with cross-functional partners (clinical, medical, tech-ops, regulatory, etc.) to efficiently manage multiple priorities, gain alignment, and drive business objectives
Strong strategic agility and verbal/written communication skills to distill complexity and effectively engage across all levels of the organization
Innovative and resilient in navigating ambiguity and matrixed organizations
Curious, with learning agility and a drive for excellence and high-quality deliverables
Organized with a systematic approach to prioritization, tracking progress, delivering results
Role model of Kite/Gilead core values, inspiring a high-performance culture and engagement

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Gilead Sciences

company-logo
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

H1B Sponsorship

Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)

Funding

Current Stage
Public Company
Total Funding
$4.41B
Key Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B

Leadership Team

leader-logo
Keeley Wettan
Senior Vice President, Legal
linkedin
leader-logo
Patrick Loerch
Senior Vice President, Clinical Data Science
linkedin
Company data provided by crunchbase